Latest / Lexington News Today | 2 Min News | The Daily News Now!
Moderna’s Flu Vaccine Gets FDA Nod | Lexington News
Moderna’s new flu vaccine, mFlusiva, just got a unanimous FDA nod for adults 50+, with plans to expand approval to younger adults—pending a follow-up study. But the final call isn’t set in stone: no permanent vaccine chief means decision-making’s murky until August 5th, and the CDC’s advisory panel, currently blocked by a judge, still needs to approve it. Why does this matter? Older adults face higher flu risks, and this mRNA tech could revolutionize flu prevention by adapting faster to evolving strains—potentially reshaping how we tackle flu seasons and even pandemics. Support the show:Get a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.